Global CBD Market Analysis By Route of Administration (Capsules, Inhalation , Aerosol Spray), Form, Product (Food Grade and Therapeutic Grade), Application (Neurogenerative Disorder, Fibromyalgia, Diabetes, Protein Bars , Energy Drinks), End User, Future Trends and Insights By Top Key Companies, Forecast To 2026Pune, India – August 14, 2019 —The global CBD Market was valued at USD 3,088.51 million in 2018, and the market is estimated to grow at USD 2,207,162.54 Million by 2026 and is expected to register a CAGR of 125.58% during the forecast period from 2019 to 2026.On the basis of routes of administration, the tincture segment accounted for the largest market share of 36.65% in 2018, with a market value of USD 1,132.07 million, and is projected to register a CAGR of 126.54% during the forecast period.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/8090Market Research Future (MRFR) recognizes Aphria Inc., Folium Biosciences, Freedom Leaf, Inc, Green Roads of Florida, LLC, CBD Health Solutions, LLC, ENDOCA, Isodiol International Inc, CV Sciences, Inc, Medical Marijuana, Inc., Canopy Growth Corporation, Elixinol Global Limited as the key players in the global CBD market.
Aug 09, 2019 (Heraldkeepers) -- Market TrendsGlobalHair Removal Devices Marketsize Anticipated to reachUSD 915.2million in 2017 and is projected to grow at aCAGR of 8.80%over the forecast period.Increasing consciousness about appearance, changing beauty standards among individuals, and growing demand for laser hair removal treatment are major factors propelling the growth of the market.Additionally, the availability of advanced hair removal devices through e-commerce portals and retail stores and growing use of such devices at home are anticipated to boost the growth of the global hair removal devices market.On the other hand, the high cost of hair removal devices and requirements of multiple treatments may restrain the market growth over the assessment period.Some of the prominent players in the global hair removal market areSyneron Medical Ltd., Sciton, Inc, Alma Lasers, Ltd., Cynosure, Inc., Cutera Inc., Lumenis Ltd, Lutronic Corporation, Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences, Inc., and Venus Concept Canada Corp
Aug 09, 2019 (AB Digital via COMTEX) -- Market TrendsThe global Cardiac Rehabilitation Devices Market is projected to reach over USD 2,839.9 million by 2023 at 6.2% CAGR during the review period of 2018 to 2023.Cardiac rehabilitation is a medically managed program designed to improve cardiovascular health.The rising prevalence of cardiac diseases, adoption of an unhealthy lifestyle and increasing geriatric population are driving the growth of the global cardiac rehabilitation devices market.However, the factor such as the high cost of cardiac rehabilitation devices and stringent government regulations hinders market growth.Cardiac Rehabilitation Devices Market Leading Companies:
Aug 09, 2019 (Heraldkeepers) -- Global mHealth Applications Market - overviewThe GlobalmHealth Applications Marketis growing with a rapid pace.mHealth has potential to change the healthcare sector and can make is more accessible, affordable and faster.However, factors such as security and confidentiality threats along with resistance to change and market volatility are the major restraining factors for the market growth, during the forecast period.Global mHealth Applications Market - Competitive AnalysisAllscripts (U.S.), Agamatrix, Inc. (U.S.), Apple Inc. (U.S.), Honeywell International Inc. (U.S.), Medtronic MiniMed, Inc. (U.S.), Vivify Health (U.S.), iHealth Labs Inc. (U.S.)and others are some of the prominent players at the forefront of competition in the Global mHealth Applications Market and are profiled in MRFR Analysis.
Aug 09, 2019 (Heraldkeepers) -- Genitourinary Drugs Marketsize to Exhibit aCAGR of 1.65%over the forecast period 2018 to 2023.Genitourinary disorders are caused by damage to the urinary tract or genital organs.The increasing cases of genitourinary disorders, surge in number of people suffering from cancer, increasing prevalence of sexually transmitted diseases, and rise in number of drugs in pipeline are the major factors driving the growth of the global genitourinary drugs market.According to the Centers for Disease Control and Prevention (CDC), more than 2.3 million Americans were diagnosed with sexually transmitted diseases in year 2017, Most common sexually transmitted diseases in American region are chlamydia, gonorrhea, and syphilis.Moreover, increase in strategic collaborations and aggressive strategy adopted by major players in the market is also responsible for the growth of the market.The European market is expected to be the second-largest due to the government initiatives for the development of healthcare sector, increasing research and development activities in the region and rise in number of chronic disorders.
Aug 08, 2019 (AB Digital via COMTEX) -- Market Trends:Global Smart Inhalers Market Is anticipated to reach USD 4.72 billion with expanding CAGR of 45% Till 2025.Asthma ranks third in the list of causes for hospitalization among children.Other diseases such as COPD are also anticipated to fuel the demand for smart inhalers in the years to come.Thus, the market players are focusing on leveraging developments in the sensor technology for capitalizing on the growing patient population.Smart Inhalers Market Competitive Analysis:
Aug 07, 2019 (AB Digital via COMTEX) -- Market Trend and Dynamics:global Real Time Health Monitoring Devices Market size to exhibit a CAGR of 13.8% across the projection period to reach a valuation of USD 110,005.0 Mn by 2025.Advancements in technology are anticipated to bring innovations in the product portfolios of the market players.This, in turn, is projected to facilitate profit maximization in the real time health monitoring devices market over the next couple of years.Real Time Health Monitoring Devices Market Competitive Dashboard:Top leaders operating in the global real time health monitoring devices market are
Aug 07, 2019 (AB Digital via COMTEX) -- The global Orthopedic Devices Market size and share is expected to exhibit a strong 4.3% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR).The global orthopedic devices market was valued at USD 43,802.1 million in 2016 and is expected to reach a valuation of USD 58,814.6 million by 2023, according to MRFR.These devices have proved immensely successful to restore mobility, reduce pain and improve the quality of life in case of millions every year.Some of the commonly used orthopedic devices include hip supports, elbow and knee braces, cervical collars, ankle and foot supports, braces and back supportsPresently the trauma management methods available are not capable of restoring the parts of the body carefully because of insufficient effective surgical tools.The increased research and development activities are expected to ensure a high growth in the orthopedic devices market soon.
They are also known as bolus injectors or patch pumps.Wearable injectors are used to subcutaneously administer insulin and other drugs that require large dose volumes and extended delivery period.The increasing prevalence of various chronic diseases, rising concern for injuries caused due to needles and increasing demand for round the clock monitoring are expected to drive the growth of the market during the forecast period.On the other hand, preference for traditional methods of drug administration and lack of skilled labor who can instruct patients about wearable injectors and its usage may hinder the growth of the market during the forecast period.Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to favorable government initiatives for the medical devices industry.The market in the Middle East & Africa is likely to account for the smallest share of the global wearable injectors market.
Immunotherapy show a better result for the treatment of melanoma cancer.Immunotherapies are used for limited number of cancer treatment mostly haematological, but they show better results where other therapy is not effective.On the other hand, long time approval and different adverse effect may restrain the growth of the marketImmunotherapy Drugs Market Key players:Some of the key players in the global Immunotherapy Drugs market areF.Further end user is segmented into hospitals & clinics, ambulatory surgical centers, others.
Aug 07, 2019 (Heraldkeepers) -- Global Infusion Pump Market OverviewGlobalInfusion Pumps Marketis expected to grow at aCAGR of 5.2 %during forecasted period 2017-2023.Infusion Pump Market Key Players:CareFusion Corporation (US), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Smiths Medical (U.K.), Becton Dickinson & Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International, Inc. (U.S.), Pfizer, Inc. (U.S.), Fresenius Kabi (Germany), Roche Diagnostics (Switzerland), Moog Inc (U.S.), Asante (US), Biomedical Solutions (US), Flowonix Medical Inc (US), Hospira, Inc (US), Micromed (UK), Mircel Medical Device (Greece), Q-Core (Israel), Stryker (US), 3M (U.S.), ICU Medical, Inc. (U.S.), and Terumo Medical Corporation (Japan) are some of the prominent players at the forefront of competition in the global infusion pump market and are profiled in MRFR Analysis.Global Infusion Pump Market - Regional Analysis:Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
The Pregnancy Tests Market is set to achieve a high CAGR in the coming forecast period.Pregnancy tests have become relatively simpler due to better awareness and acceptance of such tests.Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios.Advances in technologies have increased the accuracy of pregnancy test kits which has increased their overall demand globally.Factors such as improving demand of self-contained and quick test results is expected to favorably bolster the development of the market in the forecast period.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2982Segmental AnalysisThe segmentation of the pregnancy test kits market is segmented on the basis of type of product, test, and end users.On the basis of type of test, the market has been segmented as Urine test for HCG, blood test for HCG, and others.On the basis of region, the market is segmented into North America, the Middle East, Europe, Africa, and the Asia Pacific.Detailed Regional AnalysisThe regional analysis of the pregnancy test kits market consists of North America, the Middle East, Europe, Africa, and Asia Pacific.
Further, all of the above-mentioned report coverage parameters are discussed across different regions like North Americas, Europe, Asia Pacific (APAC) and Middle East & Africa (MEA).The global safety lancet market is expected to grow at an estimated CAGR of 11.8% from 2017 to 2023.Safety lancets are one of the widely used alternative device to obtain the blood samples.Lancets are receiving global recognition and acceptance due to its several convenient characteristics which gives them an edge over the traditional methods for vein puncture.The major applications of the safety lancets are capillary blood micro sampling, cholesterol test, HBO and HIV screening test, blood group test, coagulation tests, allergy tests and many other blood based tests.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/550Safety lancets are introduced in 1994 by Medlance with the initiation button and T-shape cover over it.They are useful to avoid needle-stick injuries and infections.In United States alone in 2014, around 2.2 million people had chronic hepatitis B virus infection.
The Lung cancer Market is growing mainly due to the changing lifestyle, and environmental pollution.According to a recent study report published by the Market Research Future, The lung cancer market is booming and expected to gain prominence over the forecast period.The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, and fatigue and chest pain.The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1185Key Players:F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer (US), Merck & Co., Inc. (US), Bristol-Myers Squibb (US), Eli Lilly and Company (US), and Sanofi (France) are some of the prominent players at the forefront of competition in the lung cancer market and are profiled in MRFR Analysis.Almost 85% of cases of lung cancer are due to long-term tobacco smoking.Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution.It has also been demonstrated that passive smokers have a 20–30% increase in risk.The treatments for lung cancer include surgery, chemotherapy, and radiotherapy with NSCLC responding better to surgery and SCLC usually responding better to chemotherapy and radiotherapy.
The Global Lithotripsy Market is anticipated to capture a moderate CAGR of 4.1 % over the forecast period.Lithotripsy is a medical procedure which involves breaking stones present in the bladder, kidney, and ureter into tiny pieces through the use of high-energy shock waves so that they can be easily passed through the urine.Lithotripsy is the most common line of treatment for kidney stones.The growing prevalence of urological disorders is one of the main factors boosting the growth of the global lithotripsy market.Additionally, one of the main advantages associated with lithotripsy is that it does not involve any incision.Growing preference for minimally invasive and noninvasive medical procedures is a prime factor augmenting the growth of the market.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/3200Competitive LandscapeEDAP TMS (France), Boston Scientific (US), Medispec LTD (US), Dornier MedTech.(Spain), Elmed Electronics & Medical Industry & Trade Inc.(Turkey), Jena Med Tech GmbH (Germany), Olympus Corporation (Japan) are the key players in the global lithotripsy market.SegmentationThe global lithotripsy market has been segmented based on type and end user.By type, the global lithotripsy market has been segmented into extracorporeal shock wave lithotripsy (ESWL), intracorporeal (endoscopic lithotripsy), percutaneous lithotripsy, and others.
As per the latest report published by Market Research Report, the global In-Vitro Fertilization (IVF) Device Market will witness an impressive CAGR of 10.50% from 2018 to 2023 and reach a valuation of over USD 12,700 Mn.IVF is a landmark achievement in assistive reproductive technology, which has become extremely popular in recent years.IVF helps in overcoming issues in conceiving or natural impregnation.IVF has a high success rate, however, is an expensive procedure and is viewed among the last resorts.Patients usually opt for IVF upon failure of the other treatments.By type, the market has been segmented into intrauterine insemination, in-vitro fertilization, intracytoplasmic sperm injection, and IVF using donor eggs.The intrauterine insemination (IUI) segment is expected to remain a highly attractive segment over the next couple years.
Acknowledging the growth of this fiercely ascending market, Market Research Future (MRFR) in its recently published study report asserts that the Global Heart Rate Monitor Market will garner colossal accruals by 2023, registering a CAGR over 13.50% throughout the forecast period (2017-2023).Heart rate monitors are used for the continuous monitoring of heartbeats and thus, the heart health.The heart rate monitor market has been accruing pervasively mainly due to the increasing trend for using wearable fitness devices over the past couple of years.Moreover, the skyrocketing demand for these devices led by the increasing emphasis of people on health and fitness escalates the market on the global platform.Currently, the world is witnessing increasing numbers of issues related to heart diseases and cardiac disorder cases.Although there are a number of procedures and innovative therapies available in the market, incidents of occurring these diseases are rising continuously and are becoming paramount concerns.Such factors are increasing the growth the heart rate monitor market, globally.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1370Major Players:Key players leading the global heart rate monitor market include Garmin Ltd.(U.S.), Apple (U.S.), Visiomed Group (France), Nike (U.S.), Samsung Electronics Co. Ltd. (South Korea), Fitbit Inc. (U.S.), Beurer GmbH (Germany), Mio Global (South Korea), Omron Healthcare (Japan), Inc., Nu-Beca & Maxcellent co. (Taiwan), LG Electronics (South Korea), Polar Electro (Finland), Motorola Solutions, Inc. (U.S.), TomTom International BV (The Netherlands), Sony (Japan), Wahoo Fitness (U.S.), MYZONE (U.S.), Moov Inc. (U.S.), Bragi (Germany), Nokia (Finland), Jabra (Germany), Scosche Industries.
Acknowledging the kind of traction, this market witnesses, Market Research Future (MRFR) in its recently published study report asserts that the Global Orthopedic Devices Market is projected to reach USD 58,814.6 MN by 2023 registering approximately 4.3 % CAGR during the review period (2017 to 2023).Healthcare segment extensively absorbs orthopedic devices for a range of surgical applications such as implants.Over the past decade, orthopedic devices have significantly evolved.Improving economic conditions provide impetus to market growth, enabling access to the quality of life & the improved healthcare.Seminal efforts and investments put in the development of innovative devices, by the key market players are fuelling the market growth.Also, the skepticism of physicians towards the advancement & efficacies of these implants affects the market growth negatively.
Cosmetic surgery is a medicinal discipline where the focus is on improving the look via surgical and medical technique.The aesthetic appeal it adds is helping the market gain attention from diverse sectors.The global cosmetic surgery market can expect a lead by 7.8% CAGR during the forecast period (2017-2023) and reach a valuation worth USD 21.97 billion by the end of 2023.Market Research Future (MRFR) revealed this information in a recently published article and focused mainly on impacts that the drivers can have on the market in the coming years, along with detailed segmental analysis and the latest updates of the competitor portfolio.This approach is to provide a holistic report that can help in the understanding the cosmetic surgery market in the coming years.The cosmetic surgery market can expect to get driven by the impacts of media, fashion, and other cultural scenarios.It is getting further thrust from the emerging medical tourism hubs like Miami and Bangkok, where the infrastructure for such treatments are widely available and at times, in a cost-effective package.
The global Brachytherapy Market is expected to exhibit a solid 10.9% CAGR over the forecast period from 2017 to 2023, according to a new market research report from Market Research Future (MRFR).The report presents a detailed analysis of the global brachytherapy market’s projected growth rate and valuation on the basis of the market’s historical performance figures and an analysis of the key trends moving the market.Brachytherapy is a type of radiation therapy performed with the source of radiation being placed near the site of treatment.The growing demand for cancer treatment is likely to be the major driving factor for the global brachytherapy market over the forecast period.The growing prevalence of various types of cancers has become a major concern for healthcare organizations around the world and the field of cancer research has gained considerable funding in the last few years from governments and private agencies alike, leading to growing demand for effective treatment methods such as brachytherapy.The high treatment rates of brachytherapy have been the key driver for the global brachytherapy market over the last few years, with the surgery gaining increasing popularity thanks to its consistent performance.Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1035The growing prevalence of various types of cancer is likely to be the dominant growth driver for the global brachytherapy market over the forecast period.The growing prevalence of prostate, breast, lung, and colorectal cancers in the developed and developing world is likely to lead a growing demand from the global brachytherapy market over the forecast period.